Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 67.28% | -111.56% | -100.81% | 200.68% | -229.09% |
| Total Depreciation and Amortization | -89.63% | 11.11% | 11.74% | 13.27% | 8.56% |
| Total Amortization of Deferred Charges | 7.17% | 228.63% | 136.34% | 80.58% | 52.53% |
| Total Other Non-Cash Items | -100.86% | -149.70% | -1.55% | -1,105.56% | 1,587.17% |
| Change in Net Operating Assets | 181.77% | 520.31% | -33.86% | -94.32% | -168.92% |
| Cash from Operations | 19.06% | -23.34% | -1,413.09% | -208.12% | -136.57% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -100.00% | -2,400.00% | -- |
| Cash from Investing | -- | -100.00% | -100.00% | -2,400.00% | -- |
| Total Debt Issued | -22.13% | -3.13% | 119.30% | 169.02% | 87.63% |
| Total Debt Repaid | 33.81% | 24.66% | 38.66% | -45.92% | -23.15% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -17.38% | 10.66% | 430.13% | 300.21% | 138.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 142.92% | -76.37% | -- | -- | -- |